ARS Investment Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,400
| Closed | -$205K | – | 144 |
|
|
2021
Q1 | $205K | Hold |
2,400
| – | – | 0.02% | 131 |
|
|
2020
Q4 | $227K | Hold |
2,400
| – | – | 0.03% | 109 |
|
|
2020
Q3 | $209K | Hold |
2,400
| – | – | 0.03% | 97 |
|
|
2020
Q2 | $210K | Buy |
+2,400
| New | +$210K | 0.04% | 65 |
|
|
2020
Q1 | – | Sell |
-2,400
| Closed | -$227K | – | 106 |
|
|
2019
Q4 | $227K | Hold |
2,400
| – | – | 0.04% | 105 |
|
|
2019
Q3 | $209K | Sell |
2,400
-2,500
| -51% | -$218K | 0.04% | 103 |
|
|
2019
Q2 | $447K | Buy |
4,900
+2,222
| +83% | +$203K | 0.08% | 101 |
|
|
2019
Q1 | $231K | Hold |
2,678
| – | – | 0.04% | 107 |
|
|
2018
Q4 | $206K | Hold |
2,678
| – | – | 0.04% | 111 |
|
|
2018
Q3 | $207K | Buy |
+2,678
| New | +$207K | 0.03% | 117 |
|
|
2016
Q1 | – | Sell |
-37,373
| Closed | -$2.88M | – | 91 |
|
|
2015
Q4 | $2.88M | Sell |
37,373
-52,982
| -59% | -$4.08M | 0.68% | 51 |
|
|
2015
Q3 | $7.44M | Buy |
90,355
+1,071
| +1% | +$88.2K | 1.71% | 24 |
|
|
2015
Q2 | $7.87M | Sell |
89,284
-2,950
| -3% | -$260K | 1.44% | 30 |
|
|
2015
Q1 | $8.15M | Sell |
92,234
-8,101
| -8% | -$716K | 1.51% | 30 |
|
|
2014
Q4 | $8.33M | Sell |
100,335
-3,119
| -3% | -$259K | 1.42% | 28 |
|
|
2014
Q3 | $8.73M | Buy |
103,454
+889
| +0.9% | +$75K | 1.33% | 29 |
|
|
2014
Q2 | $8.32M | Buy |
102,565
+13,921
| +16% | +$1.13M | 1.29% | 28 |
|
|
2014
Q1 | $6.75M | Sell |
88,644
-4,584
| -5% | -$349K | 1.19% | 31 |
|
|
2013
Q4 | $6.72M | Sell |
93,228
-5,419
| -5% | -$390K | 1.13% | 31 |
|
|
2013
Q3 | $6.78M | Sell |
98,647
-6,735
| -6% | -$463K | 1.16% | 31 |
|
|
2013
Q2 | $6.68M | Buy |
+105,382
| New | +$6.68M | 1.17% | 32 |
|